No abstract available
MeSH terms
-
Animals
-
Antibodies, Monoclonal / chemistry
-
Antibodies, Monoclonal / pharmacokinetics
-
Antibodies, Monoclonal, Humanized
-
Benzoquinones
-
Bibenzyls / pharmacology
-
Diagnostic Imaging / methods
-
Diagnostic Imaging / trends*
-
Down-Regulation
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / drug effects
-
ErbB Receptors / genetics
-
Gefitinib
-
HSP90 Heat-Shock Proteins / metabolism
-
Heterocyclic Compounds, 1-Ring / chemistry
-
Humans
-
Lactams, Macrocyclic
-
Magnetic Resonance Imaging
-
Molecular Probe Techniques*
-
Mutation
-
Neoplasms / drug therapy
-
Neoplasms / pathology
-
Phthalazines / pharmacology
-
Physiological Phenomena / drug effects
-
Positron-Emission Tomography / methods*
-
Protein Binding
-
Protein Kinase Inhibitors / pharmacology
-
Pyridines / pharmacology
-
Quinazolines / pharmacology
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
-
Receptor Protein-Tyrosine Kinases / drug effects*
-
Receptor Protein-Tyrosine Kinases / metabolism
-
Receptor, ErbB-2 / drug effects
-
Receptor, ErbB-2 / metabolism
-
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
-
Receptors, Vascular Endothelial Growth Factor / drug effects
-
Rifabutin / analogs & derivatives*
-
Rifabutin / metabolism
-
Rifabutin / pharmacology
-
Stilbenes / pharmacology
-
Tissue Distribution / physiology
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Benzoquinones
-
Bibenzyls
-
HSP90 Heat-Shock Proteins
-
Heterocyclic Compounds, 1-Ring
-
Lactams, Macrocyclic
-
Phthalazines
-
Protein Kinase Inhibitors
-
Pyridines
-
Quinazolines
-
Stilbenes
-
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
-
Rifabutin
-
tanespimycin
-
vatalanib
-
combretastatin
-
ErbB Receptors
-
Receptor Protein-Tyrosine Kinases
-
Receptor, ErbB-2
-
Receptors, Vascular Endothelial Growth Factor
-
Trastuzumab
-
Gefitinib